DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 060456
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 060456 describes PENICILLIN-VK, which is a drug marketed by Teva and is included in two NDAs. It is available from seven suppliers. Additional details are available on the PENICILLIN-VK profile page.
The generic ingredient in PENICILLIN-VK is penicillin v potassium. There are ninety-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
The generic ingredient in PENICILLIN-VK is penicillin v potassium. There are ninety-two drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.
Summary for 060456
| Tradename: | PENICILLIN-VK |
| Applicant: | Teva |
| Ingredient: | penicillin v potassium |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 060456
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PENICILLIN-VK | penicillin v potassium | FOR SOLUTION;ORAL | 060456 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-4125 | 0093-4125-73 | 100 mL in 1 BOTTLE (0093-4125-73) |
| PENICILLIN-VK | penicillin v potassium | FOR SOLUTION;ORAL | 060456 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-4125 | 0093-4125-74 | 200 mL in 1 BOTTLE (0093-4125-74) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 125MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AA | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SOLUTION;ORAL | Strength | EQ 250MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
